Mars Innovation and Evotec Ag Establish Academic Bridge “Lab150” in Toronto
Toronto, Sept. 14, 2017 MaRS Innovation and Evotec AG today announced the launch of “LAB150”. This transformational Toronto-based partnership will give Canada access to the world-class infrastructure and drug discovery expertise of Evotec, and pair it with cutting-edge drug discovery projects emerging from the 15 Member institutions of MaRS Innovation.
“LAB150 represents an extraordinary opportunity for Canada to bridge the drug discovery gap with the objective of stimulating the formation of new ventures in Ontario and of developing ground-breaking therapies to benefit Canadians and others around the world. LAB150 is an additional building block aimed at enhancing the increasingly important Canadian drug discovery research and associated commercialization”
“We are delighted to expand our academic BRIDGE network and partnerships together with MaRS Innovation. The dramatic reduction of search costs for capital for the first translational work packages of academic science, early validation of experiments, and industry proven drug discovery processes will add a highly valuable new tool to the Canadian ecosystem of innovation”
For the full press release click here